CClinicalTrials.gg
CompletedNCT00129649Updated Feb 5, 2020Results posted

Service Development: Assessing Non-attendance Rates in Outpatient Clinics

An interventional study of Telephone reminder call in Asthma, Sleep Apnea Syndromes and Tuberculosis, sponsored by Imperial College London. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-02-05.

Sponsored by Imperial College London · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
504
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Many studies have shown a high non-attendance rate in hospital outpatient clinics. The investigators have found a non-attendance rate of 25% in their asthma clinics and would like to investigate whether a reminder phone call will improve attendance rates. Patients will be randomised into two groups; one group will receive a reminder phone call one week prior to their hospital consultation and the other group will be managed in the standard manner (i.e. no reminder of any sort). The phone calls will be carried out on a Friday afternoon by a respiratory nurse specialist and a research officer for two asthma clinics based on a Wednesday morning and a Thursday afternoon.

Read the detailed description

Many studies have shown a high non-attendance rate in hospital outpatient clinics. The investigators have found a non-attendance rate of 25% in their asthma clinics and would like to investigate whether a reminder phone call will improve attendance rates. Patients will be randomised into two groups; one group will receive a reminder phone call one week prior to their hospital consultation and the other group will be managed in the standard manner (i.e. no reminder of any sort). The phone calls will be carried out on a Friday afternoon by a respiratory nurse specialist and a research officer for two asthma clinics based on a Wednesday morning and a Thursday afternoon.

To have an 80% chance of detecting a 10% reduction in non-attendance rates (at 5%) 500 patients are required for this study. The rate of non-attendance will be monitored for all the patients in both groups and some demographic information will be recorded for each patient(age, sex, diagnosis and home postcode).

02

Conditions studied

  • Asthma
  • Sleep Apnea Syndromes
  • Tuberculosis
  • COPD

Keywords

  • Telephone reminder
03

In context

Tuberculosis

1,417 studies on the registry are indexed under Tuberculosis; 208 are open to participants now.

This study's enrollment of 504 is above the median of 150 across 952 interventional studies indexed under Tuberculosis.

Browse Tuberculosis studies →

Lead sponsor

Imperial College London is the lead sponsor of 824 studies on the registry; 178 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients with appointments booked for 2 respiratory outpatient clinics

Exclusion criteria

Exclusion criteria

Patients likely to only need one appointment

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
504 participants (actual)

Study arms

  • No intervention
    control group

    This group received usual care and did not receive a telephone reminder

  • Active comparator
    telephone reminder group

    This group received a telephone reminder for their clinic appointment

    Behavioral: Telephone reminder call

Interventions

  • BehavioralTelephone reminder call
06

What researchers measure

Primary outcomes

  1. Attendance Rates at Respiratory Outpatient Clinics

    rates of attendance measured for scheduled clinics - attended patients

    Time frame: after phone call within 1 week

07

Results

Posted Feb 5, 2020

Participant flow

Participant flow — Overall Study
MilestoneControl GroupTelephone Reminder Group
Started258246
Completed182181
Not completed7665
Withdrew: Withdrawal by subject7665

Outcome measures

PrimaryAttendance Rates at Respiratory Outpatient Clinics

rates of attendance measured for scheduled clinics - attended patients

Time frame:
after phone call within 1 week
Reported as:
Count of participants · Participants
Attendance Rates at Respiratory Outpatient Clinics
ParticipantsControl GroupTelephone Reminder Group
Attendance Rates at Respiratory Outpatient Clinics18389
Statistical analysis
  • Control Group vs Telephone Reminder Group · Chi-squared · p = 0.004

Adverse events

Collected over 1 week. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control Group0/258 (0%)0/258 (0%)0/258 (0%)
Telephone Reminder Group0/246 (0%)0/246 (0%)0/246 (0%)

Baseline characteristics

Baseline characteristics were not collected

Age, Customized
Age, CustomizedControl GroupTelephone Reminder GroupTotal
Sex/Gender, Customized
Sex/Gender, CustomizedControl GroupTelephone Reminder GroupTotal
Race and Ethnicity Not Collected
Race and Ethnicity Not CollectedControl GroupTelephone Reminder GroupTotal
Region of Enrollment
Region of Enrollment(participants)Control GroupTelephone Reminder GroupTotal
08

Study locations

1 site
  • NHLI Imperial College
    London, W6 8RF, United Kingdom
09

References and documents

Publications

  • Roberts N, Meade K, Partridge M. The effect of telephone reminders on attendance in respiratory outpatient clinics. J Health Serv Res Policy. 2007 Apr;12(2):69-72. doi: 10.1258/135581907780279567. PubMed 17407654 ↗

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00129649
Lead sponsor
Imperial College London
Responsible party
Sponsor
First posted
Aug 12, 2005
Start date
Oct 2005
Primary completion
Oct 2006
Completion
Nov 2006
Results posted
Feb 5, 2020
Last update
Feb 5, 2020

Study contacts

Martyn R Partridge, MD FRCP
principal investigator · Imperial College London

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion